date,title,source
Oct-18-18,"Detailed Research: Economic Perspectives on Cerus, AdvanSix, Spark Therapeutics, Imperva, Central Garden & Pet, and Francesca's  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Oct-23-18,"Cerus to Release Third Quarter 2018 Results on November 1, 2018",Business Wire
Oct-31-18,Cerus Receives FDA Breakthrough Device Designation for Pathogen-Reduced Cryoprecipitate,Business Wire
Nov-01-18,Cerus: 3Q Earnings Snapshot,Associated Press
Nov-01-18,Cerus Corporation Reports Third Quarter 2018 Results,Business Wire
Nov-07-18,Edited Transcript of CERS earnings conference call or presentation 1-Nov-18 8:15pm GMT,Thomson Reuters StreetEvents
Nov-08-18,Edited Transcript of CERS earnings conference call or presentation 1-Nov-18 8:15pm GMT,Thomson Reuters StreetEvents
Nov-09-18,Cerus to Present at the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum,Business Wire
Nov-12-18,"Report: Developing Opportunities within Lexicon Pharmaceuticals, Cray, RCI Hospitality, Sanmina, Diamond Offshore Drilling, and Cerus  Future Expectations, Projections Moving into 2018",GlobeNewswire
Nov-15-18,Does Cerus Corporation (NASDAQ:CERS) Have A Particularly Volatile Share Price?,Simply Wall St.
